Repeat Dose Tolerance Study of Regadenoson in Healthy Subjects

NCT01918995 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Regadenoson
DRUG: Placebo

Sponsor

Astellas Pharma Global Development, Inc.